NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Advaxis, Inc., (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Lm) biotechnology company, and the Science and Technology Directorate of the Department of Homeland Security (DHS) have signed the previously announced cooperative research and development agreement (CRADA).
